These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8525207

  • 1. [Allogenic bone marrow transplantation in the treatment of malignant hematologic disease].
    Barriga F, Bertín P, Baeza R, Pereira J, Schwartzmann L, Oliva J, Ocqueteau M, Sapunar F, Duhalde M, Lira P.
    Rev Med Chil; 1995 May; 123(5):605-11. PubMed ID: 8525207
    [Abstract] [Full Text] [Related]

  • 2. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC, McGuire TR.
    Clin Pharm; 1985 May; 4(2):149-60. PubMed ID: 3886273
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 4. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S, Naparstek E, Nagler A, Ackerstein A, Kapelushnik J, Or R.
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [Abstract] [Full Text] [Related]

  • 6. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
    Kusminsky G, Foncuberta MC, Aversa L, Drelichman G, Freigeiro D, Burgos R, Irrazabal C, Gonzalez G, Dictar M, Niborski R, Kohan A, Sanchez Avalos JC.
    Medicina (B Aires); 2000 Dec; 60(2):179-87. PubMed ID: 10962806
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J.
    Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
    [Abstract] [Full Text] [Related]

  • 9. Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors.
    Demuynck H, Verhoef GE, Zachee P, Emonds MP, van der Schueren E, van den Berghe H, Vandenberghe P, Casteels-Van Daele M, Boogaerts MA.
    Bone Marrow Transplant; 1996 May; 17(5):745-51. PubMed ID: 8733692
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A, Söhngen D, Minning H, Meckenstock G, Aul C, Schneider W.
    Praxis (Bern 1994); 1996 Mar 19; 85(12):378-86. PubMed ID: 8643901
    [Abstract] [Full Text] [Related]

  • 15. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ, Díaz de Heredia C, Olivé T, Bastida P, Llort A, Armadans L, Torrabadella M, Massuet L.
    Haematologica; 2003 Mar 19; 88(3):290-9. PubMed ID: 12651268
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women.
    Singhal S, Powles R, Treleaven J, Horton C, Swansbury GJ, Mehta J.
    Bone Marrow Transplant; 1996 Dec 19; 18(6):1049-55. PubMed ID: 8971372
    [Abstract] [Full Text] [Related]

  • 18. Allogeneic bone marrow transplantation: experience with 92 patients.
    Selby GB, Saez RA, Epstein RB, Slease RB, Confer DL.
    J Okla State Med Assoc; 1993 Dec 19; 86(12):599-603. PubMed ID: 8126587
    [Abstract] [Full Text] [Related]

  • 19. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings].
    Morimoto T, Hattori K, Yabe H, Yabe M, Hinohara T, Shimizu T, Matsumoto M, Hagihara M, Tsuji K, Kato S.
    Rinsho Ketsueki; 1998 Sep 19; 39(9):631-9. PubMed ID: 9796395
    [Abstract] [Full Text] [Related]

  • 20. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E, Bandini G, Bonini A, Santucci MA, Martinelli G, Rosti G, Testoni N, Zaccaria A, Tura S.
    Haematologica; 1998 Mar 19; 83(3):231-6. PubMed ID: 9573677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.